Internet Archive Scholar

Supplementary_materials – Supplemental material for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer

Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang, Lawrence W.C. Chan
2020 Figshare  

Preserved Fulltext

fulltext thumbnail
Web Archive Capture PDF (254.1 kB)
https://web.archive.org/web/20200620030532/https://s3-eu-west-1.amazonaws.com/pstorage-sage-1076303800/23235293/Supplementary_materials.pdf

A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL. The file type is application/pdf.

Supplemental material, Supplementary_materials for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer by Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang and Lawrence W.C. Chan in Therapeutic Advances in Respiratory Disease
doi:10.25384/sage.12514445.v1 fatcat:plvxyf27aba4zedqpmly7go32m
Open Access
Citation

Fengfeng Wang, Fei Meng, Sze Chuen Cesar Wong, William C.S. Cho, Sijun Yang, Lawrence W.C. Chan. "Supplementary_materials – Supplemental material for Combination therapy of gefitinib and miR-30a-5p may overcome acquired drug resistance through regulating the PI3K/AKT pathway in non-small cell lung cancer." Figshare (2020)